Jill Murphy, Associate Editor

These biomarkers may be able to control inflammation in the body once infected with COVID-19 and can help determine the seriousness of the infection, the researchers noted.

Evidence of a causal relationship between the onset of allergic disease and mental health was limited, suggesting that the observational associations found were due to confounding or other forms of bias.

The study sought to highlight the issues with the correct routing of discontinued medications, which increases the risk of medication safety events.

The analysis found that patients’ quality of life did not change significantly over time during treatment with immune checkpoint inhibitors.

The research team analyzed links between pesticide exposure and the risk of kidney dysfunction in 41,847 people using data from the USA National Health and Nutrition Examination Survey.

The approval is based on data from a phase 3 placebo-controlled trial that evaluated the efficacy and safety of dupilumab combined with standard-of-care therapy in children with uncontrolled moderate-to-severe asthma.

The objective of the study was to prove that increased COVID-19 severity may be linked to poor oral health status, especially in patients with cardiovascular diseases.

Regular dialysis or kidney transplants are common treatment options that were disrupted after the beginning of COVID-19.

The vaccine is used to prevent cervical cancer and other cancers, such as vulvar, vaginal, and oropharyngeal.

They added that this is one of the first proofs of concept illustrating the power of an AI model for identifying parameters associated with relapse that the human brain could not detect.

The study aimed to examine the impact of masking and social distancing practices used to control the spread of COVID-19.

The majority of treatment-related adverse events (TRAEs) were grade 1-2 in severity, and no patients experienced dose-limiting toxicities during the 28 days following initial treatment.

The researchers used a body composition analysis of patients with Crohn disease in a collaboration with gastroenterology and surgical specialists.

The paper reviews the safety profile of solriamfetol in treating ES associated with OSA or narcolepsy and discusses subject areas such as pharmacology, clinical efficacy, and tolerability of the drug.

The researchers also demonstrated that ketone supplements may be a novel therapy for protecting and improving brain health in people with obesity who are at risk of developing neurocognitive impairment.

As the researchers searched for an antibiotic to pair up with the antibacterial bacteriophage, they found that they could treat the infection with the bacteriophage alone.

Between October 2011 and February 2013, UKLS researchers randomized 4055 high-risk participants to either a single invitation to screening with LDCT or to no screening.

Soliman is ecstatic to celebrate the 4th annual #WomenPharmacistDay and that the pharmacy landscape is continuing to recognize the contributions of women in the field.

This approval will provide further treatment options for younger children living with HIV, according to a ViiV press release.

The designation was based on data from the DESTINY-Breast03 phase 3 trial, and this is now the second BTD for trastuzumab deruxtecan in breast cancer, bringing its total number of BTDs to 4, according to an AstraZeneca press release.

The objective of this study was to evaluate the safety and immunogenicity of the live attenuated zoster vaccine (ZVL) in patients receiving TNFis, according to the study authors.

The national guidelines recommend a heart-healthy diet to help manage weight and control blood pressure, while also emphasizing dietary patterns rather than individual foods and nutrients.

Additionally, the ITT-E population showed both treatment arms showing a high proportion of participants with plasma HIV-1 RNA c/mL with dolutegravir/lamivudine demonstrating non-inferior virologic suppression to the TAF-based regimen.

The researchers noted the importance of maintaining vaccination rates for conditions that can lead to respiratory issues, especially with COVID-19 cases still raising concern throughout the United States.

Cemiplimab-rwlc is being developed by Regeneron and Sanofi under a global collaboration agreement.

The results were compared to those in the previous Pfizer-BioNTech study in people between 16 and 25 years of age who were immunized with 30 μg doses.

The combination maintained superior OS and response benefits versus sunitinib in both patients with intermediate- and poor-risk prognostic factors, the primary endpoint population, and across all randomized patients.

A new study examined 3 different cases of chronic urticaria being treated with cyclosporine and patients who developed reactivation of recurrent herpes zoster (HZ) following COVID-19 vaccination.

Khalili and his colleagues have completed preclinical studies that have shown that EBT-101 can effectively excise HIV proviral DNA from the genomes of different cells and tissues, including HIV-infected human cells and cells and tissues of humanized mice.

An anti-vascular endothelial growth factor therapy, ranibizumab prevents vision loss in patients with retinal vascular disorders, which can cause irreversible blindness or visual impairments in adults.